StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Announces Evaluation Agreement with Atomwise Inc.
September 17, 2018 8:10 AM
Pfizer Inc. (NYSE: PFE) and Atomwise Inc., a leader in Artificial Intelligence (AI) for drug discovery and design, have entered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Management Comments
Next Articles
Atomwise Enters Into an Evaluation Agreement with Pfizer
September 17, 2018 8:01 AM
Pfizer (PFE) Announces Positive Phase 2 Data in Alopecia Areata at 2018 EADV Congress
September 17, 2018 5:50 AM
Roche steps up efficiency drive to take sting out of biosimilars
September 13, 2018 12:49 PM
Mylan N.V. (MYL) Gains on Chatter
September 13, 2018 9:49 AM